109
Views
0
CrossRef citations to date
0
Altmetric
Clinical feature - Original research

Effect of inpatient breast cancer education and risk assessment on mammography utilization among hospitalized women post discharge

, &
Pages 132-137 | Received 05 Oct 2021, Accepted 10 Mar 2022, Published online: 20 Mar 2022

References

  • American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2021.
  • Mariotto AB, Enewold L, Zhao J, et al. Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Biomarkers Prev. 2020Jul;29(7):1304–1312. Epub 2020 Jun 10. PMID: 32522832.
  • U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 2020 submission data (1999-2018). U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. released in Jun 2021. www.cdc.gov/cancer/dataviz
  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021 [published correction appears in CA Cancer J Clin. 2021 Jul;71(4):359]. CA Cancer J Clin. 2021;71(1):7–33.
  • Helvie MA, Bevers TB. Screening mammography for average-risk women: the controversy and NCCN’s Position. J Natl Compr Canc Netw. 2018;16(11):1398–1404.
  • Bevers TB, Helvie M, Bonaccio E, et al. Breast cancer screening and diagnosis,version 3.2018,NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(11):1362–1389.
  • Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998–2005.
  • Cancer Trends Progress Report. National Cancer Institute, NIH, DHHS, Bethesda, MD, July 2021, http://progressreport.cancer.gov. Last accessed Dec 2021
  • Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–1792.
  • Kalager M, Zelen M, Langmark F, et al. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203–1210.
  • Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms [published correction appears in Ann Intern Med. 2010 Jan 19;152(2):136]. Ann Intern Med. 2009;151(10):738–747.
  • American Cancer Society. Breast cancer facts and figures 2019-2020. Atlanta GA: American Cancer Society; 2019.
  • Morelli V. An introduction to primary care in underserved populations: definitions, scope, and challenges. Prim Care. 2017;44(1):1–9.
  • Khaliq W, Visvanathan K, Landis R, et al. Breast cancer screening preferences among hospitalized women. J Womens Health (Larchmt). 2013;22(7):637–642.
  • Khaliq W, Jelovac D, Wright SM. Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study. BMJ Open. 2016;6(11):e012550.
  • Masi CM, Blackman DJ, Peek ME. Interventions to enhance breast cancer screening, diagnosis, and treatment among racial and ethnic minority women. Med Care Res Rev. 2007;64(5 Suppl):195S–242S.
  • Luckmann R, White MJ, Costanza ME, et al. Implementation and process evaluation of three interventions to promote screening mammograms delivered for 4 years in a large primary care population. Transl Behav Med. 2017Sep;7(3):547–556. PMID: 28452044; PMCID: PMC5645284.
  • Vernon SW, McQueen A, Tiro JA, et al. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis. J Natl Cancer Inst. 2010;102(14):1023–1039.
  • Boling W, Laufman L, Lynch GR, et al. Increasing mammography screening through inpatient education. J Cancer Educ. 2005;20(4):247–250.
  • Khaliq W, Landis R, Wright SM. Improving breast cancer screening adherence among hospitalized women. J Womens Health (Larchmt). 2017;26(10):1094–1098.
  • US Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement [published correction appears in Ann Intern Med. Ann Intern Med. 2009;151(10): 716–236. DOI:https://doi.org/10.7326/0003-4819-151-10-200911170-00008.
  • Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–1886.
  • Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91(18):1541–1548.
  • Gail MH, Costantino JP, Bryant J, et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer [published correction appears in J Natl Cancer Inst 2000 Feb 2;92(3):275]. J Natl Cancer Inst. 1999;91(21):1829–1846.
  • Rockhill B, Spiegelman D, Byrne C, et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93(5):358–366.
  • Gail MH, Costantino JP, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in African American women [published correction appears in J Natl Cancer Inst. 2008 Aug 6;100(15):1118] [published correction appears in J Natl Cancer Inst. 2008 Mar 5;100(5):373]. J Natl Cancer Inst. 2007;99(23):1782–1792.
  • Matsuno RK, Costantino JP, Ziegler RG, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011;103(12):951–961.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • last access Dec 2021. https://www.komen.org/breast-cancer/screening/self-awareness and /http://ww5.komen.org/BreastCancer/Mammography.html (no longer available)
  • www.cdc.gov/cancer/breast/ [cited 2022 Mar 14].
  • Clarke TC, Endeshaw M, Duran D, et al. Breast cancer screening among women by nativity, birthplace, and length of time in the United States. National Health Statistics Reports; no 129. Hyattsville MD: National Center for Health Statistics; 2019 [Published Oct 2019. Accessed 2019. Accessed Aug 27, 2020 Oct 2019. Accessed Aug 27].
  • Katz D, Tengekyon AJ, Kahan NR, et al. Patient and physician characteristics affect adherence to screening mammography: a population-based cohort study. PLoS One. 2018;13(3):e0194409.
  • Rahman SM, Dignan MB, Shelton BJ. Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older. Ethn Dis. 2003;13(4):477–484.
  • Lee H, Ghebre R, Le C, et al. Mobile phone multilevel and multimedia messaging intervention for breast cancer screening: pilot randomized controlled trial. JMIR Mhealth Uhealth. 2017;5(11):e154.
  • Nuño T, Martinez ME, Harris R, et al. A Promotora-administered group education intervention to promote breast and cervical cancer screening in a rural community along the U.S.-Mexico border: a randomized controlled trial. Cancer Causes Control. 2011;22(3):367–374.
  • Deding U, Henig AS, Salling A, et al. Sociodemographic predictors of participation in colorectal cancer screening. Int J Colorectal Dis. 2017;32(8):1117–1124.
  • Wang H, Qiu F, Gregg A, et al. Barriers and facilitators of colorectal cancer screening for patients of rural accountable care organization clinics: a multilevel analysis. J Rural Health. 2018;34(2):202–212.
  • Schueler KM, Chu PW, Smith-Bindman R. Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt). 2008;17(9):1477–1498.
  • Phillips KA, Van Bebber S, Marshall D, et al. A review of studies examining stated preferences for cancer screening. Prev Chronic Dis. 2006;3(3):A75.
  • Joynt KE, Orav EJ, Jha AK. Thirty-day readmission rates for Medicare beneficiaries by race and site of care. Jama. 2011;305(7):675–681.
  • Kind AJ, Jencks S, Brock J, et al. Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study. Ann Intern Med. 2014;161(11):765–774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.